Nomura Holdings Inc. Acquires Shares of 26,376 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nomura Holdings Inc. acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 26,376 shares of the medical instruments supplier's stock, valued at approximately $501,000.

A number of other hedge funds also recently bought and sold shares of XRAY. Vanguard Group Inc. grew its stake in shares of DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the period. First Eagle Investment Management LLC increased its position in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the last quarter. Nuance Investments LLC increased its position in shares of DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 2.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after purchasing an additional 314,343 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on XRAY. Barrington Research upped their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research report on Monday, May 12th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Finally, Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.36.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.38 on Friday, hitting $15.47. 2,475,144 shares of the company traded hands, compared to its average volume of 2,968,748. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.25. The business has a 50-day simple moving average of $14.47 and a 200 day simple moving average of $17.08. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market capitalization of $3.08 billion, a P/E ratio of -7.47, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.42 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.14%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.